CCA
ASPN icon

Cruiser Capital Advisors’s Aspen Aerogels ASPN Stock Holding History

Cruiser Capital Advisors’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$123K – 27
2020
Q1 		$123K Buy
+20,000
New +$162K 0.16% 22

Other funds holding ASPN

GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Cruiser Capital Advisors's ASPN Position: Q2 2020 in Review

Cruiser Capital Advisors sold out of Aspen Aerogels (ASPN) in Q2 2020, closing a stake of 20,000 shares — an estimated $123K sold.

Cruiser Capital Advisors first reported a position in ASPN in Q1 2020 and held it in 1 quarter. The position peaked at $123K in Q1 2020. 67 funds tracked by Wall St. Rank hold ASPN as of Q2 2020.

  • Cruiser Capital Advisors reported no remaining Aspen Aerogels position as of Q2 2020 after selling out during the quarter.
  • Cruiser Capital Advisors sold 20,000 Aspen Aerogels shares in Q2 2020, an estimated $123K.
  • Cruiser Capital Advisors first reported a position in Aspen Aerogels in Q1 2020 and held it in 1 quarter.
  • Cruiser Capital Advisors's Aspen Aerogels position peaked at $123K in Q1 2020.
  • 67 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2020.

Based on Cruiser Capital Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.